Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Interview

Identifying and mitigating risks in the viral vector supply chain

Claire Wartel & Ulises Villavicencio


VECTOR CHANNEL: RAW MATERIALS


Claire Wartel has a PhD in Molecular Pharmacology and Pharmacochemistry from the University of Strasbourg (France, 1999). After several post-docs in different prestigious universities, Claire joined Polyplustransfection in 2004 as Cell Biology project leader and participated in the development of our flagship product jetPRIME®. Claire has taken Quality responsibility since 2007, and nowadays manages the department of Quality and Regulatory Affairs.

Ulises Villavicencio attended California State University, Long Beach (CSULB) where he earned a Bachelor’s Degree in Anthropology and focused on Archaeometry. Ulises participated in numerous archaeological research projects, domestic and international, and assisted in various analytical projects at CSULB’s Institute for Integrative Research in Materials, Environments, and Societies to further analytical research in Archaeometry via chemistry-based applications. Ulises applied his education and experience in Quality test environments where he then expanded into the auditing field in 2015. Since then, Ulises has focused his attention on improving Quality and Compliance programs for the security and assurance of patient safety, where he manages the Supplier Qualification program in his current role.

Open access

 

Affiliations

Claire Wartel
Director of Quality and Compliance,
Polyplus-transfection

Ulises Villavicencio
Quality Auditor,
Audentes Therapeutics
San Francisco, CA, USA

Twitter IconVisit Our Blog